RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

RBC Capital Markets adjusted its price target for Westlake Chemical (NYSE:WLK) stock, reducing it to $147.00 from the ...

Analysts at RBC Capital Markets have initiated coverage on two Spanish banks, Bankinter (BME:BKT) and CaixaBank (BME:CABK), ...

Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital ...

Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to ...

The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...

RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270.

RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, ...

RBC Capital upgraded Hexcel (HXL) to Outperform from Sector Perform with a price target of $74, up from $68. While it is early to have high conviction in an aerospace recovery, Hexcel is one ...

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...

RBC Capital Markets analysts have downgraded T-Mobile to Sector Perform from Outperform and reduced their price target to $240 per share from $255.While acknowledging the company's strong ...